Michele Garufi

Nicox Ophthalmics, Inc. develops ocular diseases treatment products. It offers extensive pipeline such as a number of clinical and pre-clinical programs that principally target ocular allergy, ocular inflammation, and blepharitis. The company was founded by Thomas Cavanagh on December 21, 2007 and is headquartered in Fort Worth, TX.

Lamed Pharma SRL provides consulting services to the pharmaceutical industry. The private company is based in Rome, Italy. The Italian company was founded by Michele Garufi.

Nano Retina Ltd. develops artificial retina designed to restore sight. It also develops an implantable bionic chip, designed to return sight to those blinded by retinal degenerative diseases. The company was founded by Yossi Gross and James R. Von Her, II in 2009 and is headquartered in Herzliya, Israel.

Novexel SA researches and develops anti-infective drugs for the treatment of bacterial and fungal infections. The firm focuses on discovery and development of novel antibiotics designed to overcome the significant global problem of microbial resistance. The company was founded in December 2004 and is headquartered in Romainville, France.

Italfarmaco SA manufactures and distributes pharmaceutical products. It develops products in areas such as gynaecology, respiratory, orthopedics, neurology, oncology, dermatology, and pediatrics. The company was founded in 1991 and is headquartered in Alcobendas, Spain.

Visufarma BV develops ophthalmology drugs. The company was founded in 2016 and is headquartered in Amsterdam, The Netherlands.